Hardell Brain Cancer Study To
Be Published, May Affect Newman Case
RCR Wireless News
Journalist: Jeffrey Silva
April 05, 2002
Lawyers for Christopher Newman in an $800
million brain-cancer lawsuit against the mobile-phone industry have notified
the federal judge overseeing the case that an unpublished study attacked by
defendants has been accepted for publication, a potentially major
development that could change the course of the case.
Sources said an epidemiology study conducted by Dr. Lennart Hardell, who
found a higher incidence of brain tumors on the sides of heads used by
mobile-phone subscribers to make and receive calls, will be published in
June by the European Journal of Cancer Prevention. Hardell is a key expert
witness for Newman, who is represented by the law firm of high-powered
Baltimore trial lawyer Peter Angelos.
At a February hearing in Baltimore federal court on the admissibility of
scientific experts,industry lawyers made much of the fact that The Lancet, a
prestigious scientific journal in the United Kingdom, had rejected Hardell's
The latest twist in the litigation comes as U.S. District Judge Catherine
Blake nears a ruling on whether to let the Newman case go to trial. The case
is being watched closely, since no mobile-phone cancer suit has succeeded,
let alone reached a jury.
At least eight brain-cancer cases against the wireless industry are pending
in courts around the country, most filed by a small group of lawyers in
Maryland and Michigan. The lawyers plan to file another six to eight
lawsuits against mobile-phone firms within the next two weeks.
On the regulatory front, the Food and Drug Administration and the Federal
Communications Commission plan shortly to launch a joint Web site on
mobile-phone health and safety. The General Accounting Office,
the investigative arm of Congress, last year criticized the agencies for not
doing enough to inform the public about wireless radiation health issues.
The government's new outreach effort comes just weeks after epidemiologist
George Carlo unveiled a Web-based health registry that collects data from
consumers who believe they've been injured from mobile-phone radiation. The
registry has attracted significant interest, recording nearly 100,000 hits
in the first two weeks.
Carlo, who managed a $28 million industry-funded research project that found
genetic damage from low-level radiofrequency radiation, has become a thorn
in the side of wireless firms and federal regulators as a result of his
harsh criticism of their efforts to address the cancer controversy.
Top of Page